Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.

Pocock, SJ; McMurray, JJ; Dobson, J; Yusuf, S; Granger, CB; Michelson, EL; Ostergren, J; Pfeffer, MA; Solomon, SD; Anker, SD; +2 more... Swedberg, KB; on behalf of the CHARM Investigators; (2008) Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. European heart journal, 29 (21). pp. 2641-50. ISSN 0195-668X DOI: https://doi.org/10.1093/eurheartj/ehn420

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/eurheartj/ehn420

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar